Cefova S 250mg/125mg Injection
Marketer
Gnova Biotech
Salt Composition
Ceftriaxone (250mg) + Sulbactam (125mg)
Overview Cefova S 250mg/125mg Injection
Cefova S 250mg/125mg Injection, a dual-action antibiotic, combats diverse bacterial infections by hindering microbial proliferation and halting infection spread. Administration must be strictly under medical guidance; missed doses should be avoided, and the prescribed treatment regimen completed regardless of symptom improvement. Premature cessation may compromise efficacy. Potential side effects include, but are not limited to, nausea, vomiting, diarrhea, and dyspepsia. Worsening side effects warrant immediate medical attention. Allergic reactions (e.g., rash, pruritus, edema, dyspnea) require immediate emergency care. Prior to initiating treatment, inform your physician of all concurrent medications and pre-existing health conditions. Pregnant or lactating individuals should seek medical counsel before use. Alcohol consumption should be avoided due to potential increased drowsiness. While generally not impairing driving ability, refrain from driving if experiencing somnolence or vertigo. Adequate rest, proper nutrition, and sufficient hydration are crucial for optimal recovery. Your doctor may order blood tests and other investigations to monitor the treatment's impact.
Primary Ingredients of Cefova S 250mg/125mg Injection
No text was provided. Please provide the text you would like me to rephrase.
Uses of Cefova S 250mg/125mg Injection
Infections caused by bacteria
Major Benefits of Cefova S 250mg/125mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Cefova S 250mg/125mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Cefova S 250mg/125mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Cefova S 250mg/125mg Injection works:
Ceftriaxone and Sulbactam, combined as Cefova S 250mg/125mg Injection, offer a dual-action approach to bacterial infection. Ceftriaxone, a third-generation cephalosporin antibiotic, disrupts bacterial cell wall synthesis, hindering their ability to multiply. Sulbactam's role as a beta-lactamase inhibitor counteracts bacterial resistance mechanisms, thus bolstering Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse interactions between Cefova S 250mg/125mg Injection and alcohol consumption.
PregnancySAFE IF PRESCRIBED
The injectable medication Cefova S (250mg/125mg) is typically deemed safe for pregnant individuals. Preclinical trials using animals have revealed minimal or no negative impacts on fetal development; however, data from human studies remain scarce.
Breast feedingCAUTION
Administering Cefova S 250mg/125mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily suspended throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administering Cefova S 250mg/125mg Injection could induce drowsiness, blurred vision, or dizziness. Refrain from operating vehicles if these effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding Cefova S 250mg/125mg Injection use in individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should use Cefova S 250mg/125mg Injection cautiously, potentially requiring dosage modification. Medical advice is recommended. Dosage alteration for Cefova S 250mg/125mg Injection is unnecessary for individuals with mild or moderate liver dysfunction.
What if you forget to take Cefova S 250mg/125mg Injection :
Should you forget a scheduled dose of Cefova S 250mg/125mg Injection, seek advice from your physician.
Facts to Know About Cefova S 250mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Anti-infective Agents |
3,018 People bought this recently